<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141665480420000%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201904019%26RESULT%3d1%26SIGN%3dV01LAlsXCERR9sXFxjrhtcfbnhw%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904019&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904019&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904019&amp;v=Mjc1OTh2SVBUWE1aYkc0SDlqTXE0OUViWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#32" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#33" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#35" data-title="1.2 治疗方法">1.2 治疗方法</a></li>
                                                <li><a href="#37" data-title="1.3 临床观察指标">1.3 临床观察指标</a></li>
                                                <li><a href="#39" data-title="1.4 临床疗效判断">1.4 临床疗效判断</a></li>
                                                <li><a href="#41" data-title="1.5 统计学处理">1.5 统计学处理</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#45" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#46" data-title="2.1 两组疗效比较">2.1 两组疗效比较</a></li>
                                                <li><a href="#49" data-title="2.2 两组心功能指标的比较">2.2 两组心功能指标的比较</a></li>
                                                <li><a href="#53" data-title="2.3 两组药物相关不良反应的比较">2.3 两组药物相关不良反应的比较</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#55" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#44" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组一般临床资料的比较&lt;/b&gt; (n=84) "><b>表</b>1 <b>两组一般临床资料的比较</b> (n=84) </a></li>
                                                <li><a href="#48" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;两组临床疗效的比较&lt;/b&gt; (n=84) "><b>表</b>2 <b>两组临床疗效的比较</b> (n=84) </a></li>
                                                <li><a href="#51" data-title="表3 两组LVEF、LVPWT和IVST的比较（&lt;image id=&quot;73&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904019_07300.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s，n=84) ">表3 两组LVEF、LVPWT和IVST的比较（<image id="73" type="formula" href="images/XXGK201904019_07300.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=84) </a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="王喆.《中国心力衰竭诊断和治疗指南2014》解读[J].中国临床医生杂志, 2016, 44 (5) :14-16." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLYS201605007&amp;v=MTA3MjFyQ1VSN3FmWnVabUZ5am5WN3ZJUHlIU2ZiRzRIOWZNcW85Rlk0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0Y=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        王喆.《中国心力衰竭诊断和治疗指南2014》解读[J].中国临床医生杂志, 2016, 44 (5) :14-16.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="Sandhu RK, Hohnloser SH, Pfeffer MA, et al.Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart Fail[J].Stroke, 2015, 46 (3) :667-672." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Relationship between degree of left ventricular dysfunction,symptom status,and risk of embolic events in patients with atrial fibrillation and heart failure">
                                        <b>[2]</b>
                                        Sandhu RK, Hohnloser SH, Pfeffer MA, et al.Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart Fail[J].Stroke, 2015, 46 (3) :667-672.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="吴海萍, 张雅红, 王贝贝.胺碘酮联合厄贝沙坦对心力衰竭合并心律失常的疗效及机制研究[J].重庆医学, 2016, 45 (1) :59-61." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=CQYX201601022&amp;v=MjkwODdmWnVabUZ5am5WN3ZJSmp6U2RyRzRIOWZNcm85SFpvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3E=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        吴海萍, 张雅红, 王贝贝.胺碘酮联合厄贝沙坦对心力衰竭合并心律失常的疗效及机制研究[J].重庆医学, 2016, 45 (1) :59-61.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="张陶莉, 张春晓.厄贝沙坦联合胺碘酮治疗老年慢性心力衰竭并阵发性心房纤颤临床观察[J].中华临床医师杂志 (电子版) , 2011, 5 (24) :7425-7426." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLYD201124062&amp;v=MDc3Mjl1Wm1GeWpuVjd2SVB5SFNhckc0SDlET3E0OURab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        张陶莉, 张春晓.厄贝沙坦联合胺碘酮治疗老年慢性心力衰竭并阵发性心房纤颤临床观察[J].中华临床医师杂志 (电子版) , 2011, 5 (24) :7425-7426.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="林小凤.美托洛尔联合厄贝沙坦治疗老年阵发性心房颤动的疗效[J].心血管康复医学杂志, 2016, 25 (3) :305-308." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201603020&amp;v=MTIyOTZWN3ZJUFRYTVpiRzRIOWZNckk5SFpJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am4=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        林小凤.美托洛尔联合厄贝沙坦治疗老年阵发性心房颤动的疗效[J].心血管康复医学杂志, 2016, 25 (3) :305-308.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" >
                                        <b>[6]</b>
                                    中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志, 2014, 42 (2) ;98-122.</a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="郭继鸿, 张萍.动态心电图学[M].北京:人民卫生出版社, 2003, 339." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CBBD&amp;filename=0007117054131999&amp;v=MDI4Mjk0NUdaZUlHQlJNOHp4VVNtRGQ5U0g3bjN4RTlmYnZuS3JpZlplWnZGeW50VTcvS0pGb1VWVjI3R2JLNUdkSEpx&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                        郭继鸿, 张萍.动态心电图学[M].北京:人民卫生出版社, 2003, 339.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="白润爱, 何勇.胺碘酮联合厄贝沙坦对充血性心力衰竭并室性心律失常的疗效观察[J].中国循证心血管医学杂志, 2016, 8 (2) :180-182." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201602018&amp;v=MDA3MTVuVjd2SU5UZlRkckc0SDlmTXJZOUViSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        白润爱, 何勇.胺碘酮联合厄贝沙坦对充血性心力衰竭并室性心律失常的疗效观察[J].中国循证心血管医学杂志, 2016, 8 (2) :180-182.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="罗骏, 杨向军, 葛郁芝, 等.兔慢性心力衰竭心房肌细胞钠离子通道重构和分子机制及厄贝沙坦的干预[J].中国心脏起搏与心电生理杂志, 2008, 22 (3) :248-251." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGXZ200803029&amp;v=MDQ1NzQ5SGJZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3ZJUHlyVGRMRzRIdG5Nckk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        罗骏, 杨向军, 葛郁芝, 等.兔慢性心力衰竭心房肌细胞钠离子通道重构和分子机制及厄贝沙坦的干预[J].中国心脏起搏与心电生理杂志, 2008, 22 (3) :248-251.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="李艳君, 李乐, 唐艳红.厄贝沙坦联合胺碘酮与单用胺碘酮比较治疗阵发性房颤的Meta分析[J].中国循证医学杂志, 2015, 15 (9) :1078-1083." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZZXZ201509013&amp;v=MDQwMjBQemZUZExHNEg5VE1wbzlFWjRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3dkk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        李艳君, 李乐, 唐艳红.厄贝沙坦联合胺碘酮与单用胺碘酮比较治疗阵发性房颤的Meta分析[J].中国循证医学杂志, 2015, 15 (9) :1078-1083.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="梁国钦, 廖华.胺碘酮联合厄贝沙坦对心力衰竭合并心律失常的疗效及机制研究[J].中华心脏与心律电子杂志, 2017, 5 (1) :21-24." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XZXL201701008&amp;v=MTEwNTdJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3ZJUFRmVFlyRzRIOWJNcm85RmI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        梁国钦, 廖华.胺碘酮联合厄贝沙坦对心力衰竭合并心律失常的疗效及机制研究[J].中华心脏与心律电子杂志, 2017, 5 (1) :21-24.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title="李利香.厄贝沙坦联合美托洛尔治疗慢性充血性心衰的疗效观察[J].中国卫生标准管理, 2017, 8 (21) :78-79." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=WSBZ201721044&amp;v=MDU5Mjl1Wm1GeWpuVjd2SU1qN0pkTEc0SDliT3JvOUJZSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        李利香.厄贝沙坦联合美托洛尔治疗慢性充血性心衰的疗效观察[J].中国卫生标准管理, 2017, 8 (21) :78-79.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title="Watanabe R, Suzuki J, Wakayama K, et al.Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal Fail[J].Hypertens Res, 2016, 39 (4) :237-244." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure">
                                        <b>[13]</b>
                                        Watanabe R, Suzuki J, Wakayama K, et al.Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal Fail[J].Hypertens Res, 2016, 39 (4) :237-244.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(04),466-469 DOI:10.3969/j.issn.1008-0074.2019.04.19            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>厄贝沙坦联合美托洛尔治疗慢性心力衰竭合并房性或室性心律失常患者的疗效</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E9%BB%8E%E4%BA%91&amp;code=42560808&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">黎云</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E9%AB%98%E6%97%A5%E6%89%AC&amp;code=35497434&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">高日扬</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E6%9E%97%E5%B0%8F%E4%BA%AE&amp;code=35496979&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">林小亮</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E6%9D%A8%E9%9D%99&amp;code=42560809&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">杨静</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E6%B5%B7%E5%8F%A3%E5%B8%82%E7%AC%AC%E5%9B%9B%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E5%BF%83%E8%A1%80%E7%AE%A1%E5%86%85%E7%A7%91&amp;code=1699733&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">海口市第四人民医院心血管内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:探讨厄贝沙坦联合美托洛尔治疗慢性心力衰竭 (CHF) 合并房性或室性心律失常患者的疗效。<b>方法</b>:2017年于我院接受治疗的CHF合并房性或室性心律失常患者168例被随机均分为美托洛尔组 (在常规治疗基础上接受美托洛尔) 和联合治疗组 (在美托洛尔组基础上加用厄贝沙坦) , 两组均治疗3个月。观察比较两组治疗前后LVEF、左室后壁厚度 (LVPWT) 、室间隔厚度 (IVST) 、临床疗效。<b>结果</b>:联合治疗组治疗总有效率显著高于美托洛尔组 (90.5%比73.8%) , <i>P</i>=0.005。与治疗前比较, 联合治疗组治疗后LVEF[ (55.16±6.52) %比 (64.24±8.72) %]显著升高, LVPWT[ (14.72±1.78) mm比 (13.27±1.14) mm]和IVST[ (10.18±1.15) mm比 (9.12±0.64) mm]显著减小, <i>P</i>均=0.001;且与美托洛尔组比较LVEF[ (56.13±6.15) %比 (64.24±8.72) %]升高更显著, LVPWT[ (14.35±1.23) mm比 (13.27±1.14) mm]和IVST [ (9.88±0.85) mm比 (9.12±0.64) mm]减小更显著, <i>P</i>均=0.001。两组药物不良反应率无显著差异, <i>P</i>=0.799。<b>结论</b>:厄贝沙坦联合美托洛尔治疗慢性心力衰竭合并房性和室性心律失常疗效显著, 安全。对于心室重构的抑制作用可能是其主要机制。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E5%8A%9B%E8%A1%B0%E7%AB%AD&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心力衰竭;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8%2C%20%E5%BF%83%E6%80%A7&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心律失常, 心性;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%8E%84%E8%B4%9D%E6%B2%99%E5%9D%A6&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">厄贝沙坦;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E7%BE%8E%E6%89%98%E6%B4%9B%E5%B0%94&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">美托洛尔;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E8%82%8C%E9%87%8D%E6%9E%84&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心肌重构;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2018-07-27</p>

            </div>
                    <h1>Therapeutic effect of irbesartan combined metoprolol on patients with chronic heart failure complicated atrial or ventricular arrhythmia</h1>
                    <h2>
                    <span>LI Yun</span>
                    <span>GAO Ri-yang</span>
                    <span>LIN Xiao-liang</span>
                    <span>YANG Jing</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, Fourth People′s Hospital of Haikou City</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>:To explore therapeutic effect of irbesartan combined metoprolol on patients with chronic heart failure (CHF) complicated atrial or ventricular arrhythmia. <b>Methods</b>:A total of 168 CHF patients with atrial or ventricular arrhythmia treated in our hospital from 2017 were randomly and equally divided into metoprolol group (received metoprolol based on routine treatment) and combined treatment group (received irbesartan based on metoprolol group) , both groups were treated for three months. LVEF, left ventricular posterior wall thickness (LVPWT) , interventricular septal thickness (IVST) before and after treatment, therapeutic effect were observed and compared between two groups. <b>Results</b>:Total effective rate of combined treatment group was significantly higher than that of metoprolol group (90.5% vs. 73.8%) , <i>P</i>=0.005. Compared with before treatment, there was significant rise in LVEF[ (55.16±6.52) % vs. (64.24±8.72) %], and significant reductions in LVPWT[ (14.72±1.78) mm vs. (13.27±1.14) mm], IVST[ (10.18±1.15) mm vs. (9.12±0.64) mm] in combined treatment group after treatment, <i>P</i>=0.001 all; and compared with metoprolol group after three-month treatment, there was significant rise in LVEF[ (56.13±6.15) % vs. (64.24±8.72) %], and significant reductions in LVPWT[ (14.35±1.23) mm vs. (13.27±1.14) mm] and IVST [ (9.88±0.85) mm vs. (9.12±0.64) mm] in combined treatment group, <i>P</i>=0.001 all. There was no significant difference in incidence rate of adverse between two groups, <i>P</i>=0.799. <b>Conclusion</b>:Irbesartan combined metoprolol possess significant therapeutic effect on patients with CHF complicated atrial or ventricular arrhythmia with good safety. Inhibition on ventricular remodeling may be its main mechanism.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Heart%20failure&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Heart failure;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Arrhythmias%2C%20cardiac&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Arrhythmias, cardiac;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Metoprolol&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Metoprolol;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Erbesartan&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Erbesartan;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2018-07-27</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="31">慢性心力衰竭 (CHF) 是大多数心血管疾病的终末转归, 随着我国居民饮食习惯的改变, 以及人口老龄化现象日益严重, 心血管疾病的发病率不断上升, CHF发生率也呈现上升趋势<citation id="59" type="reference"><link href="5" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。CHF时心房和心室结构重构以及对生物电节律的损伤, 常常会伴发心律失常的发生, 其中以室性心律失常为主, 约占80%, 但是房性心律失常也不容忽视, 伴发的房颤常常会导致脑栓塞的发生, 增加患者的治疗难度<citation id="60" type="reference"><link href="7" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。厄贝沙坦是一种选择性血管紧张素-II受体拮抗剂, 临床观察显示其对房性和室性心律失常均可显效<citation id="62" type="reference"><link href="9" rel="bibliography" /><link href="11" rel="bibliography" /><sup>[<a class="sup">3</a>,<a class="sup">4</a>]</sup></citation>, 美托洛尔选择性阻断β1受体, 对心律失常, 特别是室上性心律失常尤其有效<citation id="61" type="reference"><link href="13" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>。本研究观察了厄贝沙坦联合美托洛尔治疗CHF合并房性和室性心律失常的疗效, 现报道如下。</p>
                </div>
                <h3 id="32" name="32" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="33" name="33">1.1 一般资料</h4>
                <div class="p1">
                    <p id="34">选择2017年1月～2017年12月于我院治疗的CHF合并房性或室性心律失常患者168例。纳入对象:符合中华心血管病杂志编辑委员会2014年制定《中国心力衰竭诊断和治疗指南》中的诊断标准<citation id="63" type="reference"><link href="15" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>, 心电图、动态心电图及超声心动图确诊的心律失常患者。排除对象:肝、脑、肺、肾等脏器功能严重障碍者, 伴发甲状腺功能异常或恶性肿瘤者, 心室率不到45次/min者, 伴发Ⅱ～Ⅲ°房室传导阻滞者。使用随机数字表法, 患者被随机均分为美托洛尔组和联合治疗组 (厄贝沙坦+美托洛尔) , 每组84例。两组性别、年龄、心律失常类型、房颤次数、室性早搏次数、NYHA心功能分级间无显著性差异 (<i>P</i>均&gt;0.05) , 具有可比性。见表1。</p>
                </div>
                <h4 class="anchor-tag" id="35" name="35">1.2 治疗方法</h4>
                <div class="p1">
                    <p id="36">美托洛尔组:给予休息、吸氧、低盐饮食、利尿、强心以及基础疾病的对症治疗, 美托洛尔口服 (美国AstraZeneca AB公司产品, 批号:20161125) , 6.25mg/d, 2次/d, 1周后调整改为12.5 mg/d, 2次/d, 疗程12周。联合治疗组在美托洛尔组基础上加用厄贝沙坦口服 (杭州赛诺菲民生制药有限公司, 批号:20161017) , 75 mg/次, 1次/d, 3d后调整改为150mg/次, 1次/d, 疗程12周。</p>
                </div>
                <h4 class="anchor-tag" id="37" name="37">1.3 临床观察指标</h4>
                <div class="p1">
                    <p id="38">治疗前和 3个月疗程结束后复查心功能, 使用美国HP-5500 型超声诊断仪检测左室射血分数 (LVEF) 、左室后壁厚度 (LVPWT) 、室间隔厚度 (IVST) 。记录治疗期间药物相关不良反应。</p>
                </div>
                <h4 class="anchor-tag" id="39" name="39">1.4 临床疗效判断</h4>
                <div class="p1">
                    <p id="40">参照Holter 疗效判定标准<citation id="64" type="reference"><link href="17" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>: ①显效:房颤、室性早搏、室性心动过速消失, 或者房颤或室性早搏较治疗前发作次数减少≥90%, 或室性心动过速消失≥90%;②有效:房颤或室性早搏较治疗前发作次数减少50%～90%, 或室性心动过速消失50%～90%; ③无效:达不到上述标准, 或者加重。</p>
                </div>
                <h4 class="anchor-tag" id="41" name="41">1.5 统计学处理</h4>
                <div class="p1">
                    <p id="42">采用SPSS 18.0软件处理实验数据, 计量资料以均数±标准差 (<image id="72" type="formula" href="images/XXGK201904019_07200.jpg" display="inline" placement="inline"><alt></alt></image>±s) 表示, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <div class="area_img" id="44">
                    <p class="img_tit"><b>表</b>1 <b>两组一般临床资料的比较</b> (n=84)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="44" border="1"><tr><td>组别</td><td>男/女<br /> (例) </td><td>年龄<br /> (岁) </td><td>房颤<br /><i>n</i> (%) </td><td>室性早搏<br /><i>n</i> (%) </td><td>室性心动<br />过速<i>n</i> (%) </td><td>房颤次数<br /> (次/周) </td><td>室性早搏<br /> (次/d) </td><td>NYHA心功能<br />Ⅱ级<i>n</i> (%) </td><td>NYHA心功能<br />Ⅲ级<i>n</i> (%) </td><td>NYHA心功能<br />Ⅳ级<i>n</i> (%) </td></tr><tr><td><br />美托洛尔组</td><td>43/41</td><td>63.27±9.16</td><td>22 (26.19) </td><td>34 (40.48) </td><td>28 (33.33) </td><td>8.35±1.72</td><td>72.53±13.62</td><td>24 (28.57) </td><td>35 (41.67) </td><td>25 (29.76) </td></tr><tr><td><br />联合治疗组</td><td>44/40</td><td>63.31±9.24</td><td>23 (27.38) </td><td>35 (41.67) </td><td>26 (32.95) </td><td>8.31±1.74</td><td>73.14±13.65</td><td>23 (27.38) </td><td>37 (44.05) </td><td>24 (28.57) </td></tr><tr><td><br /><i>t</i>/<i>χ</i><sup>2</sup></td><td>0.024</td><td>0.028</td><td></td><td>0.111</td><td></td><td>0.150</td><td>0.290</td><td>0.097</td><td></td><td></td></tr><tr><td><br /><i>P</i></td><td>0.877</td><td>0.978</td><td></td><td>0.946</td><td></td><td>0.881</td><td>0.772</td><td>0.953</td><td></td><td></td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h3 id="45" name="45" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="46" name="46">2.1 两组疗效比较</h4>
                <div class="p1">
                    <p id="47">观察组治疗总有效率为90.5%, 显著高于美托洛尔组的73.8% (<i>χ</i><sup>2</sup>=7.954, <i>P</i>=0.005) 。见表2。</p>
                </div>
                <div class="area_img" id="48">
                    <p class="img_tit"><b>表</b>2 <b>两组临床疗效的比较</b> (n=84)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="48" border="1"><tr><td><br />组别</td><td>显效<br /><i>n</i> (%) </td><td>有效<br /><i>n</i> (%) </td><td>无效<br /><i>n</i> (%) </td><td>总有效率<br /><i>n</i> (%) </td></tr><tr><td><br />美托洛尔组</td><td>34 (40.5) </td><td>28 (33.3) </td><td>22 (26.2) </td><td>62 (73.8) </td></tr><tr><td><br />联合治疗组</td><td>49 (58.3) </td><td>27 (32.1) </td><td>8 (9.5) </td><td>76 (90.5) <sup>△△</sup></td></tr><tr><td><br /><i>χ</i><sup>2</sup>/<i>P</i></td><td></td><td></td><td></td><td>7.954/0.005</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与美托洛尔组比较△△<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="49" name="49">2.2 两组心功能指标的比较</h4>
                <div class="p1">
                    <p id="50">治疗前两组LVEF、LVPWT和IVST差异无显著性 (<i>P</i>均&gt;0.05) 。治疗3个月后, 美托洛尔组上述指标无显著变化 (<i>P</i>均&gt;0.05) ;与治疗前比较, 联合治疗组治疗3个月后LVEF显著升高, LVPWT、IVST显著减小 (<i>P</i>均=0.001) ;与美托洛尔组比较, 联合治疗组治疗3个月后LVEF升高更显著, LVPWT、IVST减小更显著 (<i>P</i>均=0.001) 。见表3。</p>
                </div>
                <div class="area_img" id="51">
                    <p class="img_tit">表3 两组LVEF、LVPWT和IVST的比较（<image id="73" type="formula" href="images/XXGK201904019_07300.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=84)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="51" border="1"><tr><td rowspan="2"><br />组别</td><td colspan="3"><br />LVEF (%) </td><td colspan="3">LVPWT (mm) </td><td colspan="3">IVST (mm) </td></tr><tr><td>治疗前</td><td>治疗后</td><td><i>t</i>/<i>P</i></td><td>治疗前</td><td>治疗后</td><td><i>t</i>/<i>P</i></td><td>治疗前</td><td>治疗后</td><td><i>t</i>/<i>P</i></td></tr><tr><td>美托洛尔组</td><td>54.72±6.34</td><td>56.13±6.15</td><td>1.463/0.145</td><td>14.76±1.82</td><td>14.35±1.23</td><td>1.711/0.085</td><td>10.14±1.13</td><td>9.88±0.85</td><td>1.685/0.094</td></tr><tr><td><br />联合治疗组</td><td>55.16±<br />6.52</td><td>64.24±<br />8.72<sup>**△△</sup></td><td>7.646/0.001</td><td>14.72±<br />1.78</td><td>13.27±<br />1.14<sup>**△△</sup></td><td>6.287/0.001</td><td>10.18±<br />1.15</td><td>9.12±<br />0.64<sup>**△△</sup></td><td>7.382/0.001</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>0.443/0.658</td><td>6.966/0.001</td><td></td><td>0.144/0.886</td><td>5.902/0.001</td><td></td><td>0.227/0.821</td><td>6.547/0.001</td><td></td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:LVEF:左室射血分数, LVPWT:左室后壁厚度, IVST:室间隔厚度。与治疗前比较*<i>P</i>&lt;0.05, **<i>P</i>&lt;0.01。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="53" name="53">2.3 两组药物相关不良反应的比较</h4>
                <div class="p1">
                    <p id="54">美托洛尔组眩晕1例、头痛2例、口干1例、恶心2例、失眠2例, 不良反应发生率为9.5% (8/84) , 联合治疗组恶心1例、呕吐1例、腹泻1例、眩晕2例、头痛1例、耳鸣1例、失眠1例、疲倦1例、不良反应发生率为10.7% (9/84) , 两组不良反应发生率无显著性差异 (<i>χ</i><sup>2</sup>=0.065, <i>P</i>=0.799) , 上述不良反应患者均可耐受, 无需停药。</p>
                </div>
                <h3 id="55" name="55" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="56">CHF是全球慢性心血管疾病防治的重要内容, 伴发的心律失常可进一步加重心力衰竭, 救治不及时常威胁患者生命安全, 因此对于CHF合并心律失常患者应积极治疗其心律失常<citation id="65" type="reference"><link href="19" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>。罗骏等<citation id="66" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>使用CHF模型兔研究发现厄贝沙坦可以减少模型兔心房肌细胞钠通道α亚单位mRNA表达, 下调心衰的心房肌细胞钠离子通道电流;李艳君等<citation id="67" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>分析了2000年到2014年关于厄贝沙坦治疗房颤的文献, 发现治疗的998例患者中使用厄贝沙坦可以控制阵发性房颤, 维持窦性心率, 并显著降低左房内径;梁国钦等<citation id="68" type="reference"><link href="25" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>的研究显示厄贝沙坦辅助治疗可以显著提高抗心律失常药物胺碘酮对心力衰竭患者室性心律失常的控制作用。李利香<citation id="69" type="reference"><link href="27" rel="bibliography" /><sup>[<a class="sup">12</a>]</sup></citation>使用厄贝沙坦联合美托洛尔治疗CHF, 结果发现疗效较单药治疗显著提高, 说明了两药联用可以发挥增效作用。本研究显示厄贝沙坦联合美托洛尔可以很好地控制CHF患者的房性和室性心律失常的发生, 疗效优于抗心律失常常用药物美托洛尔的单药治疗。</p>
                </div>
                <div class="p1">
                    <p id="57">血管紧张素Ⅱ水平升高可刺激成纤维细胞增生, 并增强成纤维细胞的胶原合成代谢, 这样就会带来脏器间质的纤维化, 心肌间质纤维化是心肌重构的病理基础, 血管紧张素II还可以激活鸟苷酸结合的调节蛋白及细胞膜上的磷脂酶C, 增加内质网钙的释放, 导致心肌细胞内钙超载, 引起心肌电重构, 这些机制均可以加重心力衰竭的心肌损伤及诱发患者的心律失常, Watanabe<citation id="70" type="reference"><link href="29" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>等的研究显示了血管紧张素II抑制剂厄贝沙坦可以显著减少心肌梗死诱发的心律失常, 梁国钦等<citation id="71" type="reference"><link href="25" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>的研究显示了厄贝沙坦在治疗CHF心律失常患者的同时也可以增强患者的心功能, 延缓患者的心肌重构。LVEF、LVPWT和IVST是临床上常用的心功能和心肌重构的监测指标, 本研究显示治疗后联合治疗组LVEF显著高于美托洛尔组, 而LVPWT和IVST显著低于美托洛尔组, 这可能与血管紧张素II抑制剂的心肌重构抑制作用相关。药物不良反应分析发现两组间无显著性差异, 发生的不良反应患者均可耐受, 停药后均可自行恢复, 无需特殊处理, 说明了联合用药的安全性。</p>
                </div>
                <div class="p1">
                    <p id="58">综上所述, 本研究显示厄贝沙坦联合美托洛尔治疗CHF合并房性和室性心律失常疗效显著, 使用安全, 对于心肌重构的抑制可能是其起效的主要机制。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLYS201605007&amp;v=MjQ0ODViRzRIOWZNcW85Rlk0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3ZJUHlIU2Y=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>王喆.《中国心力衰竭诊断和治疗指南2014》解读[J].中国临床医生杂志, 2016, 44 (5) :14-16.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Relationship between degree of left ventricular dysfunction,symptom status,and risk of embolic events in patients with atrial fibrillation and heart failure">

                                <b>[2]</b>Sandhu RK, Hohnloser SH, Pfeffer MA, et al.Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart Fail[J].Stroke, 2015, 46 (3) :667-672.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=CQYX201601022&amp;v=MTg5MjlqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3ZJSmp6U2RyRzRIOWZNcm85SFpvUUtESDg0dlI0VDY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>吴海萍, 张雅红, 王贝贝.胺碘酮联合厄贝沙坦对心力衰竭合并心律失常的疗效及机制研究[J].重庆医学, 2016, 45 (1) :59-61.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLYD201124062&amp;v=MTc2NjM0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3ZJUHlIU2FyRzRIOURPcTQ5RFpvUUtESDg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>张陶莉, 张春晓.厄贝沙坦联合胺碘酮治疗老年慢性心力衰竭并阵发性心房纤颤临床观察[J].中华临床医师杂志 (电子版) , 2011, 5 (24) :7425-7426.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201603020&amp;v=MjIxMjl1Wm1GeWpuVjd2SVBUWE1aYkc0SDlmTXJJOUhaSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>林小凤.美托洛尔联合厄贝沙坦治疗老年阵发性心房颤动的疗效[J].心血管康复医学杂志, 2016, 25 (3) :305-308.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" >
                                    <b>[6]</b>
                                中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志, 2014, 42 (2) ;98-122.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CBBD&amp;filename=0007117054131999&amp;v=MTg2ODE3L0tKRm9VVlYyN0diSzVHZEhKcTQ1R1plSUdCUk04enhVU21EZDlTSDduM3hFOWZidm5LcmlmWmVadkZ5bnRV&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b>郭继鸿, 张萍.动态心电图学[M].北京:人民卫生出版社, 2003, 339.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201602018&amp;v=MTI0NzVuVjd2SU5UZlRkckc0SDlmTXJZOUViSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>白润爱, 何勇.胺碘酮联合厄贝沙坦对充血性心力衰竭并室性心律失常的疗效观察[J].中国循证心血管医学杂志, 2016, 8 (2) :180-182.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGXZ200803029&amp;v=MjQ0Njl1Wm1GeWpuVjd2SVB5clRkTEc0SHRuTXJJOUhiWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>罗骏, 杨向军, 葛郁芝, 等.兔慢性心力衰竭心房肌细胞钠离子通道重构和分子机制及厄贝沙坦的干预[J].中国心脏起搏与心电生理杂志, 2008, 22 (3) :248-251.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZZXZ201509013&amp;v=Mjk3MjR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3dklQemZUZExHNEg5VE1wbzlFWjRRS0RIODQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>李艳君, 李乐, 唐艳红.厄贝沙坦联合胺碘酮与单用胺碘酮比较治疗阵发性房颤的Meta分析[J].中国循证医学杂志, 2015, 15 (9) :1078-1083.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XZXL201701008&amp;v=MDYzODlqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WN3ZJUFRmVFlyRzRIOWJNcm85RmJJUUtESDg0dlI0VDY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>梁国钦, 廖华.胺碘酮联合厄贝沙坦对心力衰竭合并心律失常的疗效及机制研究[J].中华心脏与心律电子杂志, 2017, 5 (1) :21-24.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=WSBZ201721044&amp;v=MjkxOTh0R0ZyQ1VSN3FmWnVabUZ5am5WN3ZJTWo3SmRMRzRIOWJPcm85QllJUUtESDg0dlI0VDZqNTRPM3pxcUI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>李利香.厄贝沙坦联合美托洛尔治疗慢性充血性心衰的疗效观察[J].中国卫生标准管理, 2017, 8 (21) :78-79.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure">

                                <b>[13]</b>Watanabe R, Suzuki J, Wakayama K, et al.Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal Fail[J].Hypertens Res, 2016, 39 (4) :237-244.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201904019" />
        <input id="dpi" type="hidden" value="300" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904019&amp;v=Mjc1OTh2SVBUWE1aYkc0SDlqTXE0OUViWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="1" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
